Intermittent preventive treatment in pregnancy with sulfadoxine- pyrimethamine: The times they are A-changin'

Clinical Infectious Diseases

Volumn 55, Issue 7, 2012, Pages 1025-1026

  Harrington, Whitney ^a   McGready, Rose ^b,c,d   Muehlenbachs, Atis ^a   Fried, Michal ^e   Nosten, Francois ^b,c,d   Duffy, Patrick ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE;

ALLELE; BLOOD SMEAR; DISEASE EXACERBATION; FEMALE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; INTERMITTENT PREVENTIVE TREATMENT; LETTER; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROPHYLAXIS; TANZANIA;

ANTIMALARIALS; FEMALE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL CARE; PYRIMETHAMINE; SULFADOXINE;

EID: 84866125603     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis568     Document Type: Letter

References (10)

1. Taylor SM, Antonia A, Chaluluka E, et al. Antenatal receipt of sulfadoxine-pyrimeth-amine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis 2012; 55:42-50.
2. Feng G, Simpson JA, Chaluluka E, Molyneux MERogerson SJ. Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS One 2010; 5:e12012.
3. Menendez C, Bardaji A, Sigauque B, et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 2008; 3:e1934.
4. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis 2011; 53:224-30.
5. Harrington WE, Mutabingwa TK, Muehlen-bachs A, et al. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A 2009; 106:9027-32.
6. Wargo AR, Huijben S, de Roode JC, Shepherd J, Read AF. Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc Natl Acad Sci U S A 2007; 104:19914-9.
7. Clark HC. The diagnostic value of the pla-cental blood film in aestivo-autumnal malaria. J Exp Med 1915; 22:427-44.
8. Taylor SM, Antonia A, Feng G, et al. Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study. Infect Genet Evol 2012; 12:282-90.
9. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ. The efficacy of antimalarial regimens containing sul-fadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 1994; 51:515-22. (Pubitemid 24378544)
10. Challis K, Osman NB, Cotiro M, Nordahl G, Dgedge M, Bergstrom S. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Trop Med Int Health 2004; 9:1066-73. (Pubitemid 39423084)